Premature ventricular contraction other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
Homa Najafi (talk | contribs) No edit summary |
Homa Najafi (talk | contribs) No edit summary |
||
| (5 intermediate revisions by the same user not shown) | |||
| Line 2: | Line 2: | ||
{{Premature ventricular contraction}} | {{Premature ventricular contraction}} | ||
{{CMG}}; {{AE}}{{Homa}} | {{CMG}}; {{AE}}{{Radwa}}{{Homa}} | ||
==Overview== | ==Overview== | ||
| Line 54: | Line 54: | ||
| colspan="1" style="text-align:center; background:LightCoral"|[[ESC guidelines classification scheme#Classification of Recommendations|Class III]] | | colspan="1" style="text-align:center; background:LightCoral"|[[ESC guidelines classification scheme#Classification of Recommendations|Class III]] | ||
|- | |- | ||
|bgcolor="LightCoral" |<nowiki></nowiki> '''1.''' [[ | |bgcolor="LightCoral" |<nowiki></nowiki> '''1.''' In [[patients]] who meet [[criteria]] for [[Implantable cardioverter defibrillator|ICD]] [[implantation]], an [[Electrophysiological|electrophysiological study]] for the sole reason of inducing [[Ventricular arrhythmias|VA]] is not indicated for [[Risk stratification tools|risk stratification]] ''([[ACC AHA Guidelines Classification Scheme#Level of Evidence|Level of Evidence: B-R]])''.<ref name="BardyLee2005">{{cite journal|last1=Bardy|first1=Gust H.|last2=Lee|first2=Kerry L.|last3=Mark|first3=Daniel B.|last4=Poole|first4=Jeanne E.|last5=Packer|first5=Douglas L.|last6=Boineau|first6=Robin|last7=Domanski|first7=Michael|last8=Troutman|first8=Charles|last9=Anderson|first9=Jill|last10=Johnson|first10=George|last11=McNulty|first11=Steven E.|last12=Clapp-Channing|first12=Nancy|last13=Davidson-Ray|first13=Linda D.|last14=Fraulo|first14=Elizabeth S.|last15=Fishbein|first15=Daniel P.|last16=Luceri|first16=Richard M.|last17=Ip|first17=John H.|title=Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure|journal=New England Journal of Medicine|volume=352|issue=3|year=2005|pages=225–237|issn=0028-4793|doi=10.1056/NEJMoa043399}}</ref><ref name="BuxtonLee1999">{{cite journal|last1=Buxton|first1=Alfred E.|last2=Lee|first2=Kerry L.|last3=Fisher|first3=John D.|last4=Josephson|first4=Mark E.|last5=Prystowsky|first5=Eric N.|last6=Hafley|first6=Gail|title=A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease|journal=New England Journal of Medicine|volume=341|issue=25|year=1999|pages=1882–1890|issn=0028-4793|doi=10.1056/NEJM199912163412503}}</ref><ref name="MossHall1996">{{cite journal|last1=Moss|first1=Arthur J.|last2=Hall|first2=W. Jackson|last3=Cannom|first3=David S.|last4=Daubert|first4=James P.|last5=Higgins|first5=Steven L.|last6=Klein|first6=Helmut|last7=Levine|first7=Joseph H.|last8=Saksena|first8=Sanjeev|last9=Waldo|first9=Albert L.|last10=Wilber|first10=David|last11=Brown|first11=Mary W.|last12=Heo|first12=Moonseong|title=Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia|journal=New England Journal of Medicine|volume=335|issue=26|year=1996|pages=1933–1940|issn=0028-4793|doi=10.1056/NEJM199612263352601}}</ref><ref name="MossZareba2002">{{cite journal|last1=Moss|first1=Arthur J.|last2=Zareba|first2=Wojciech|last3=Hall|first3=W. Jackson|last4=Klein|first4=Helmut|last5=Wilber|first5=David J.|last6=Cannom|first6=David S.|last7=Daubert|first7=James P.|last8=Higgins|first8=Steven L.|last9=Brown|first9=Mary W.|last10=Andrews|first10=Mark L.|title=Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction|journal=New England Journal of Medicine|volume=346|issue=12|year=2002|pages=877–883|issn=0028-4793|doi=10.1056/NEJMoa013474}}</ref> | ||
'''2.''' [[ | '''2.''' An [[Electrophysiological|electrophysiological study]] is not recommended for [[Risk stratification tools|risk stratification]] for [[Ventricular arrhythmias|VA]] in the setting of [[long QT syndrome]], [[catecholaminergic polymorphic ventricular tachycardia]], [[short QT syndrome]], or [[Early repolarization syndrome|early repolarization syndromes]] ''([[ACC AHA Guidelines Classification Scheme#Level of Evidence|Level of Evidence: B-R]])''.<ref name="BhandariShapiro1985">{{cite journal|last1=Bhandari|first1=A K|last2=Shapiro|first2=W A|last3=Morady|first3=F|last4=Shen|first4=E N|last5=Mason|first5=J|last6=Scheinman|first6=M M|title=Electrophysiologic testing in patients with the long QT syndrome.|journal=Circulation|volume=71|issue=1|year=1985|pages=63–71|issn=0009-7322|doi=10.1161/01.CIR.71.1.63}}</ref><ref name="GiustettoDi Monte2006">{{cite journal|last1=Giustetto|first1=C.|last2=Di Monte|first2=F.|last3=Wolpert|first3=C.|last4=Borggrefe|first4=M.|last5=Schimpf|first5=R.|last6=Sbragia|first6=P.|last7=Leone|first7=G.|last8=Maury|first8=P.|last9=Anttonen|first9=O.|last10=Haissaguerre|first10=M.|last11=Gaita|first11=F.|title=Short QT syndrome: clinical findings and diagnostic-therapeutic implications|journal=European Heart Journal|volume=27|issue=20|year=2006|pages=2440–2447|issn=0195-668X|doi=10.1093/eurheartj/ehl185}}</ref><ref name="GiustettoSchimpf2011">{{cite journal|last1=Giustetto|first1=Carla|last2=Schimpf|first2=Rainer|last3=Mazzanti|first3=Andrea|last4=Scrocco|first4=Chiara|last5=Maury|first5=Philippe|last6=Anttonen|first6=Olli|last7=Probst|first7=Vincent|last8=Blanc|first8=Jean-Jacques|last9=Sbragia|first9=Pascal|last10=Dalmasso|first10=Paola|last11=Borggrefe|first11=Martin|last12=Gaita|first12=Fiorenzo|title=Long-Term Follow-Up of Patients With Short QT Syndrome|journal=Journal of the American College of Cardiology|volume=58|issue=6|year=2011|pages=587–595|issn=07351097|doi=10.1016/j.jacc.2011.03.038}}</ref><ref name="MahidaDerval2015">{{cite journal|last1=Mahida|first1=Saagar|last2=Derval|first2=Nicolas|last3=Sacher|first3=Frederic|last4=Leenhardt|first4=Antoine|last5=Deisenhofer|first5=Isabel|last6=Babuty|first6=Dominique|last7=Schläpfer|first7=Jürg|last8=de Roy|first8=Luc|last9=Frank|first9=Robert|last10=Yli-Mayry|first10=Sinikka|last11=Mabo|first11=Philippe|last12=Rostock|first12=Thomas|last13=Nogami|first13=Akihiko|last14=Pasquié|first14=Jean-Luc|last15=de Chillou|first15=Christian|last16=Kautzner|first16=Josef|last17=Jesel|first17=Laurence|last18=Maury|first18=Philippe|last19=Berte|first19=Benjamin|last20=Yamashita|first20=Seigo|last21=Roten|first21=Laurent|last22=Lim|first22=Han S.|last23=Denis|first23=Arnaud|last24=Bordachar|first24=Pierre|last25=Ritter|first25=Philippe|last26=Probst|first26=Vincent|last27=Hocini|first27=Mélèze|last28=Jaïs|first28=Pierre|last29=Haïssaguerre|first29=Michel|title=Role of Electrophysiological Studies in Predicting Risk of Ventricular Arrhythmia in Early Repolarization Syndrome|journal=Journal of the American College of Cardiology|volume=65|issue=2|year=2015|pages=151–159|issn=07351097|doi=10.1016/j.jacc.2014.10.043}}</ref><ref name="PrioriNapolitano2002">{{cite journal|last1=Priori|first1=Silvia G.|last2=Napolitano|first2=Carlo|last3=Memmi|first3=Mirella|last4=Colombi|first4=Barbara|last5=Drago|first5=Fabrizio|last6=Gasparini|first6=Maurizio|last7=DeSimone|first7=Luciano|last8=Coltorti|first8=Fernando|last9=Bloise|first9=Raffaella|last10=Keegan|first10=Roberto|last11=Cruz Filho|first11=Fernando E.S.|last12=Vignati|first12=Gabriele|last13=Benatar|first13=Abraham|last14=DeLogu|first14=Angelica|title=Clinical and Molecular Characterization of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia|journal=Circulation|volume=106|issue=1|year=2002|pages=69–74|issn=0009-7322|doi=10.1161/01.CIR.0000020013.73106.D8}}</ref> | ||
''<nowiki/>'' | ''<nowiki/>'' | ||
Latest revision as of 03:21, 15 July 2020
|
Premature ventricular contraction Microchapters |
|
Differentiating Premature Ventricular Contraction from other Disorders |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Premature ventricular contraction other diagnostic studies On the Web |
|
FDA on Premature ventricular contraction other diagnostic studies |
|
CDC onPremature ventricular contraction other diagnostic studies |
|
Premature ventricular contraction other diagnostic studies in the news |
|
Blogs on Premature ventricular contraction other diagnostic studies |
|
to Hospitals Treating Premature ventricular contraction other diagnostic studies |
|
Risk calculators and risk factors for Premature ventricular contraction other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Radwa AbdElHaras Mohamed AbouZaied, M.B.B.S[2] Homa Najafi, M.D.[3]
Overview
There are no other diagnostic studies associated with [disease name].
OR
[Diagnostic study] may be helpful in the diagnosis of [disease name]. Findings suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
OR
Other diagnostic studies for [disease name] include [diagnostic study 1], which demonstrates [finding 1], [finding 2], and [finding 3], and [diagnostic study 2], which demonstrates [finding 1], [finding 2], and [finding 3].
Other Diagnostic Studies
There are no other diagnostic studies associated with [disease name].
OR
[Diagnostic study] may be helpful in the diagnosis of [disease name]. Findings suggestive of/diagnostic of [disease name] include:
- [Finding 1]
- [Finding 2]
- [Finding 3]
OR
Other diagnostic studies for [disease name] include:
- [Diagnostic study 1], which demonstrates:
- [Finding 1]
- [Finding 2]
- [Finding 3]
- [Diagnostic study 2], which demonstrates:
- [Finding 1]
- [Finding 2]
- [Finding 3]
2017 AHA/ACC/HRS Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death (DO NOT EDIT)[1]
Recommendations for Electrophysiological Study
| Class IIa |
| 1. In patients with ischemic cardiomyopathy, NICM, or adult congenital heart disease who have syncope or other VA symptoms and who do not meet indications for a primary prevention ICD, an electrophysiological study can be useful for assessing the risk of sustained VT (Level of Evidence: B-R).[2][3][4][5][6][7][8] |
| Class III |
| 1. In patients who meet criteria for ICD implantation, an electrophysiological study for the sole reason of inducing VA is not indicated for risk stratification (Level of Evidence: B-R).[9][10][11][12]
2. An electrophysiological study is not recommended for risk stratification for VA in the setting of long QT syndrome, catecholaminergic polymorphic ventricular tachycardia, short QT syndrome, or early repolarization syndromes (Level of Evidence: B-R).[13][14][15][16][17]
|
References
- ↑ Al-Khatib, Sana M.; Stevenson, William G.; Ackerman, Michael J.; Bryant, William J.; Callans, David J.; Curtis, Anne B.; Deal, Barbara J.; Dickfeld, Timm; Field, Michael E.; Fonarow, Gregg C.; Gillis, Anne M.; Granger, Christopher B.; Hammill, Stephen C.; Hlatky, Mark A.; Joglar, José A.; Kay, G. Neal; Matlock, Daniel D.; Myerburg, Robert J.; Page, Richard L. (2018). "2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death". Circulation. 138 (13). doi:10.1161/CIR.0000000000000549. ISSN 0009-7322.
- ↑ Buxton, Alfred E.; Lee, Kerry L.; DiCarlo, Lorenzo; Gold, Michael R.; Greer, G. Stephen; Prystowsky, Eric N.; O'Toole, Michael F.; Tang, Anthony; Fisher, John D.; Coromilas, James; Talajic, Mario; Hafley, Gail (2000). "Electrophysiologic Testing to Identify Patients with Coronary Artery Disease Who Are at Risk for Sudden Death". New England Journal of Medicine. 342 (26): 1937–1945. doi:10.1056/NEJM200006293422602. ISSN 0028-4793.
- ↑ Buxton, Alfred E.; Lee, Kerry L.; Hafley, Gail E.; Wyse, D. George; Fisher, John D.; Lehmann, Michael H.; Pires, Luis A.; Gold, Michael R.; Packer, Douglas L.; Josephson, Mark E.; Prystowsky, Eric N.; Talajic, Mario R. (2002). "Relation of Ejection Fraction and Inducible Ventricular Tachycardia to Mode of Death in Patients With Coronary Artery Disease". Circulation. 106 (19): 2466–2472. doi:10.1161/01.CIR.0000037224.15873.83. ISSN 0009-7322.
- ↑ Costantini, Otto; Hohnloser, Stefan H.; Kirk, Malcolm M.; Lerman, Bruce B.; Baker, James H.; Sethuraman, Barathi; Dettmer, Mary M.; Rosenbaum, David S. (2009). "The ABCD (Alternans Before Cardioverter Defibrillator) Trial". Journal of the American College of Cardiology. 53 (6): 471–479. doi:10.1016/j.jacc.2008.08.077. ISSN 0735-1097.
- ↑ Bourke, John P.; Richards, David A.B.; Ross, David L.; Wallace, Elizabeth M.; McGuire, Mark A.; Uther, John B. (1991). "Routine programmed electrical stimulation in survivors of acute myocardial infarction for prediction of spontaneous ventricular tachyarrhythmias during follow-up: Results, optimal stimulation protocol and cost-effective screening". Journal of the American College of Cardiology. 18 (3): 780–788. doi:10.1016/0735-1097(91)90802-G. ISSN 0735-1097.
- ↑ Schmitt, Claus; Barthel, Petra; Ndrepepa, Gjin; Schreieck, Jürgen; Plewan, Andreas; Schömig, A; Schmidt, Georg (2001). "Value of programmed ventricular stimulation for prophylactic internal cardioverter-defibrillator implantation in postinfarction patients preselected by noninvasive risk stratifiers". Journal of the American College of Cardiology. 37 (7): 1901–1907. doi:10.1016/S0735-1097(01)01246-3. ISSN 0735-1097.
- ↑ Bailey, James J; Berson, Alan S; Handelsman, Harry; Hodges, Morrison (2001). "Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction". Journal of the American College of Cardiology. 38 (7): 1902–1911. doi:10.1016/S0735-1097(01)01667-9. ISSN 0735-1097.
- ↑ Hilfiker, Gabriela (2015). "Utility of electrophysiological studies to predict arrhythmic events". World Journal of Cardiology. 7 (6): 344. doi:10.4330/wjc.v7.i6.344. ISSN 1949-8462.
- ↑ Bardy, Gust H.; Lee, Kerry L.; Mark, Daniel B.; Poole, Jeanne E.; Packer, Douglas L.; Boineau, Robin; Domanski, Michael; Troutman, Charles; Anderson, Jill; Johnson, George; McNulty, Steven E.; Clapp-Channing, Nancy; Davidson-Ray, Linda D.; Fraulo, Elizabeth S.; Fishbein, Daniel P.; Luceri, Richard M.; Ip, John H. (2005). "Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure". New England Journal of Medicine. 352 (3): 225–237. doi:10.1056/NEJMoa043399. ISSN 0028-4793.
- ↑ Buxton, Alfred E.; Lee, Kerry L.; Fisher, John D.; Josephson, Mark E.; Prystowsky, Eric N.; Hafley, Gail (1999). "A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease". New England Journal of Medicine. 341 (25): 1882–1890. doi:10.1056/NEJM199912163412503. ISSN 0028-4793.
- ↑ Moss, Arthur J.; Hall, W. Jackson; Cannom, David S.; Daubert, James P.; Higgins, Steven L.; Klein, Helmut; Levine, Joseph H.; Saksena, Sanjeev; Waldo, Albert L.; Wilber, David; Brown, Mary W.; Heo, Moonseong (1996). "Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia". New England Journal of Medicine. 335 (26): 1933–1940. doi:10.1056/NEJM199612263352601. ISSN 0028-4793.
- ↑ Moss, Arthur J.; Zareba, Wojciech; Hall, W. Jackson; Klein, Helmut; Wilber, David J.; Cannom, David S.; Daubert, James P.; Higgins, Steven L.; Brown, Mary W.; Andrews, Mark L. (2002). "Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction". New England Journal of Medicine. 346 (12): 877–883. doi:10.1056/NEJMoa013474. ISSN 0028-4793.
- ↑ Bhandari, A K; Shapiro, W A; Morady, F; Shen, E N; Mason, J; Scheinman, M M (1985). "Electrophysiologic testing in patients with the long QT syndrome". Circulation. 71 (1): 63–71. doi:10.1161/01.CIR.71.1.63. ISSN 0009-7322.
- ↑ Giustetto, C.; Di Monte, F.; Wolpert, C.; Borggrefe, M.; Schimpf, R.; Sbragia, P.; Leone, G.; Maury, P.; Anttonen, O.; Haissaguerre, M.; Gaita, F. (2006). "Short QT syndrome: clinical findings and diagnostic-therapeutic implications". European Heart Journal. 27 (20): 2440–2447. doi:10.1093/eurheartj/ehl185. ISSN 0195-668X.
- ↑ Giustetto, Carla; Schimpf, Rainer; Mazzanti, Andrea; Scrocco, Chiara; Maury, Philippe; Anttonen, Olli; Probst, Vincent; Blanc, Jean-Jacques; Sbragia, Pascal; Dalmasso, Paola; Borggrefe, Martin; Gaita, Fiorenzo (2011). "Long-Term Follow-Up of Patients With Short QT Syndrome". Journal of the American College of Cardiology. 58 (6): 587–595. doi:10.1016/j.jacc.2011.03.038. ISSN 0735-1097.
- ↑ Mahida, Saagar; Derval, Nicolas; Sacher, Frederic; Leenhardt, Antoine; Deisenhofer, Isabel; Babuty, Dominique; Schläpfer, Jürg; de Roy, Luc; Frank, Robert; Yli-Mayry, Sinikka; Mabo, Philippe; Rostock, Thomas; Nogami, Akihiko; Pasquié, Jean-Luc; de Chillou, Christian; Kautzner, Josef; Jesel, Laurence; Maury, Philippe; Berte, Benjamin; Yamashita, Seigo; Roten, Laurent; Lim, Han S.; Denis, Arnaud; Bordachar, Pierre; Ritter, Philippe; Probst, Vincent; Hocini, Mélèze; Jaïs, Pierre; Haïssaguerre, Michel (2015). "Role of Electrophysiological Studies in Predicting Risk of Ventricular Arrhythmia in Early Repolarization Syndrome". Journal of the American College of Cardiology. 65 (2): 151–159. doi:10.1016/j.jacc.2014.10.043. ISSN 0735-1097.
- ↑ Priori, Silvia G.; Napolitano, Carlo; Memmi, Mirella; Colombi, Barbara; Drago, Fabrizio; Gasparini, Maurizio; DeSimone, Luciano; Coltorti, Fernando; Bloise, Raffaella; Keegan, Roberto; Cruz Filho, Fernando E.S.; Vignati, Gabriele; Benatar, Abraham; DeLogu, Angelica (2002). "Clinical and Molecular Characterization of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia". Circulation. 106 (1): 69–74. doi:10.1161/01.CIR.0000020013.73106.D8. ISSN 0009-7322.